EC
IRMD icon

EntryPoint Capital’s iRadimed IRMD Stock Holding History

EntryPoint Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,028
Closed -$203K – 844
2024
Q3 		$203K Sell
4,028
-182
-4% -$8.4K 0.12% 472
2024
Q2 		$185K Buy
4,210
+811
+24% +$34.5K 0.27% 23
2024
Q1 		$150K Buy
+3,399
New +$150K 0.13% 219

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EntryPoint Capital's IRMD Position: Q4 2024 in Review

EntryPoint Capital sold out of iRadimed (IRMD) in Q4 2024, closing a stake of 4,028 shares — an estimated $203K sold.

EntryPoint Capital first reported a position in IRMD in Q1 2024 and held it in 3 quarters. The position peaked at $203K in Q3 2024. 166 funds tracked by Wall St. Rank hold IRMD as of Q4 2024.

  • EntryPoint Capital reported no remaining iRadimed position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 4,028 iRadimed shares in Q4 2024, an estimated $203K.
  • EntryPoint Capital first reported a position in iRadimed in Q1 2024 and held it in 3 quarters.
  • EntryPoint Capital's iRadimed position peaked at $203K in Q3 2024.
  • 166 funds tracked by Wall St. Rank held iRadimed as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.